Literature DB >> 32668009

Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosis.

Wei Zhen Yeh1,2, Melissa Gresle1,2, Vilija Jokubaitis1,2, Jim Stankovich1, Anneke van der Walt1,2, Helmut Butzkueven1,2.   

Abstract

Initially recognised as an important factor for bone health, vitamin D is now known to have a range of effects on the immune system. Vitamin D deficiency is associated with an increased risk of multiple sclerosis (MS), a chronic immune-mediated demyelinating disease of the CNS. In this review, we explore the links between vitamin D deficiency, MS risk, and disease activity. We also discuss the known immune effects of vitamin D supplementation and the relevance of these observations to the immunopathology of MS. Finally, we review the existing evidence for vitamin D supplementation as an MS therapy, highlighting several recent clinical studies and trials.
© 2020 The British Pharmacological Society.

Entities:  

Keywords:  cholecalciferol; genetic; immune; multiple sclerosis; supplementation; therapeutic; transcriptome; treatment; vitamin D

Mesh:

Substances:

Year:  2020        PMID: 32668009      PMCID: PMC7443468          DOI: 10.1111/bph.15201

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  139 in total

1.  A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers.

Authors:  Aideen C Allen; Siobhan Kelly; Sharee A Basdeo; Katie Kinsella; Keith J Mulready; Kingston H G Mills; Niall Tubridy; Cathal Walsh; Jennifer J Brady; Michael Hutchinson; Jean M Fletcher
Journal:  Mult Scler       Date:  2012-03-28       Impact factor: 6.312

2.  Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis.

Authors:  Steve Simpson; Wendy Wang; Peter Otahal; Leigh Blizzard; Ingrid A F van der Mei; Bruce V Taylor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-06-19       Impact factor: 10.154

3.  Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin.

Authors:  X Q Tian; T C Chen; L Y Matsuoka; J Wortsman; M F Holick
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

4.  Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.

Authors:  Vittorio Martinelli; Gloria Dalla Costa; Bruno Colombo; Dacia Dalla Libera; Alessandro Rubinacci; Massimo Filippi; Roberto Furlan; Giancarlo Comi
Journal:  Mult Scler       Date:  2013-07-08       Impact factor: 6.312

5.  Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials.

Authors:  N Keum; D H Lee; D C Greenwood; J E Manson; E Giovannucci
Journal:  Ann Oncol       Date:  2019-05-01       Impact factor: 32.976

6.  Sun exposure and vitamin D are independent risk factors for CNS demyelination.

Authors:  R M Lucas; A-L Ponsonby; K Dear; P C Valery; M P Pender; B V Taylor; T J Kilpatrick; T Dwyer; A Coulthard; C Chapman; I van der Mei; D Williams; A J McMichael
Journal:  Neurology       Date:  2011-02-08       Impact factor: 9.910

7.  Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.

Authors:  Pavan Bhargava; Sonya U Steele; Emmanuelle Waubant; Nisha R Revirajan; Jacqueline Marcus; Marieme Dembele; Sandra D Cassard; Bruce W Hollis; Ciprian Crainiceanu; Ellen M Mowry
Journal:  Mult Scler       Date:  2015-08-18       Impact factor: 6.312

8.  Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS.

Authors:  Milena A Gianfrancesco; Pernilla Stridh; Brooke Rhead; Xiaorong Shao; Edison Xu; Jennifer S Graves; Tanuja Chitnis; Amy Waldman; Timothy Lotze; Teri Schreiner; Anita Belman; Benjamin Greenberg; Bianca Weinstock-Guttman; Gregory Aaen; Jan M Tillema; Janace Hart; Stacy Caillier; Jayne Ness; Yolanda Harris; Jennifer Rubin; Meghan Candee; Lauren Krupp; Mark Gorman; Leslie Benson; Moses Rodriguez; Soe Mar; Ilana Kahn; John Rose; Shelly Roalstad; T Charles Casper; Ling Shen; Hong Quach; Diana Quach; Jan Hillert; Maria Bäärnhielm; Anna Hedstrom; Tomas Olsson; Ingrid Kockum; Lars Alfredsson; Catherine Metayer; Catherine Schaefer; Lisa F Barcellos; Emmanuelle Waubant
Journal:  Neurology       Date:  2017-03-29       Impact factor: 9.910

Review 9.  Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis.

Authors:  Stanley L Cohan; Elisabeth B Lucassen; Meghan C Romba; Stefanie N Linch
Journal:  Biomedicines       Date:  2019-03-11

10.  THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets.

Authors:  Stephen P H Alexander; Eamonn Kelly; Alistair Mathie; John A Peters; Emma L Veale; Jane F Armstrong; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; O Peter Buneman; John A Cidlowski; Arthur Christopoulos; Anthony P Davenport; Doriano Fabbro; Michael Spedding; Jörg Striessnig; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2019-12       Impact factor: 8.739

View more
  5 in total

Review 1.  Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosis.

Authors:  Wei Zhen Yeh; Melissa Gresle; Vilija Jokubaitis; Jim Stankovich; Anneke van der Walt; Helmut Butzkueven
Journal:  Br J Pharmacol       Date:  2020-08-05       Impact factor: 8.739

Review 2.  Does the High Prevalence of Vitamin D Deficiency in African Americans Contribute to Health Disparities?

Authors:  Bruce N Ames; William B Grant; Walter C Willett
Journal:  Nutrients       Date:  2021-02-03       Impact factor: 5.717

Review 3.  Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis.

Authors:  Michael Hecker; Jan Bühring; Brit Fitzner; Paulus Stefan Rommer; Uwe Klaus Zettl
Journal:  Biomolecules       Date:  2021-10-13

4.  Vitamin C and Vitamin D-friends or foes in modulating γδ T-cell differentiation?

Authors:  Christian Peters; Katharina Klein; Dieter Kabelitz
Journal:  Cell Mol Immunol       Date:  2022-07-07       Impact factor: 22.096

Review 5.  Systematic Review of Studies on Telomere Length in Patients with Multiple Sclerosis.

Authors:  Jan Bühring; Michael Hecker; Brit Fitzner; Uwe Klaus Zettl
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.